Review




Structured Review

EPS Corporation web-based randomization system
The risk of bias of included trials (Authors judgment/Evidence for judgment).
Web Based Randomization System, supplied by EPS Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/secure+web-based+randomisation+program/web+based+randomization+system/pmc08283176-21-5-8
Average 90 stars, based on 1 article reviews
web-based randomization system - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat"

Article Title: Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat

Journal: Frontiers in Pharmacology

doi: 10.3389/fphar.2021.658079

The risk of bias of included trials (Authors judgment/Evidence for judgment).
Figure Legend Snippet: The risk of bias of included trials (Authors judgment/Evidence for judgment).

Techniques Used: Sequencing, Capsules

Related Articles

other:

Article Title: Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
Article Snippet: Assignment was implemented by a web-based randomization system (EPS Corporation, Tokyo, Japan), conducted with a dynamic allocation method using a biased-coin minimization approach.

Article Title: Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
Article Snippet: Study Drug Administration Assignment was implemented by a web-based randomization system (EPS Corporation, Tokyo, Japan), conducted with a dynamic allocation method using a biased-coin minimization approach.

Article Title: Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.
Article Snippet: Primary aldosteronism (PA) is a common curable cause of hypertension.. Adrenal venous sampling (AVS) is recommended for subtype diagnosis but is a difficult procedure.. Recently, an increased prevalence of PA was reported, creating a greater demand for treatment of the condition in clinical facilities.

Article Title: Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
Article Snippet: Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Centre, Osaka, Japan (K Toyoda MD, T Yamaguchi MD); Clinical Research Centre for Medicine, International University of Health and Welfare, Tokyo, Japan (S Uchiyama MD); Centre for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Centre, Tokyo, Japan (S Uchiyama); Department of Neurology, University of California, San Francisco, CA, USA (J D Easton MD); Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan (K Kimura MD); Department of Neurology, Tokyo Saiseikai Central Hospital, Tokyo, Japan (H Hoshino MD); Department of Neurosurgery, Kobe City Medical Centre General Hospital, Kobe, Japan (N Sakai MD); Clinical Research Institute and Department of Cerebrovascular Medicine and Neurology, National Hospital Organisation Kyushu Medical Centre, Fukuoka, Japan (Y Okada MD); Department of Neurology (K Tanaka MD) and Division of Biostatistics and Clinical Epidemiology (H Origasa PhD), University of Toyama, Toyama, Japan; Department of Neurology, Senri Chuo Hospital, Toyonaka, Japan (H Naritomi MD); Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan (K Houkin MD); Department of Neurology, Ichinomiya Nishi Hospital, Ichinomiya, Japan (K Yamaguchi MD); Department of Neurosurgery, Kushiro Rosai Hospital, Kushiro, Japan (M Isobe MD); and Headquarters of the Iseikai Medical Corporation, Osaka, Japan (K Minematsu MD) Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial

Article Title: Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat
Article Snippet: (NCT02952092) , Low risk/By a web-based randomization system (EPS corporation, tokyo, Japan) , Low risk/Dynamic allocation was conducted using a biased-coin minimization approach , Low risk/Double blind study , Low risk/Double blind study , Low risk/All dropped-out patients have been reported , Low risk/Information for this study available from Clincialtrials.gov , outcomes reported as planned in Clinicaltrials.gov.

Article Title: Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)
Article Snippet: Randomisation was based on dynamic allocation by a minimisation method in a centralised web-based system (EPS Corporation, Tokyo, Japan).

Sequencing:

Article Title: Targeted therapy for advanced anaplastic lymphoma kinase (<i>ALK</i> )-rearranged non-small cell lung cancer
Article Snippet: .. Cochrane Database of Systematic Reviews Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Quote: "Patients were randomly assigned in a 1:1 ratio, using a stratified permuted-block method" Allocation concealment (selection bias) Low risk Quote: "an interactive web response system (IxRS; EPS Corporation, Tokyo, Japan) using a randomisation code generated independently by the IxRS vendor." ..

Selection:

Article Title: Targeted therapy for advanced anaplastic lymphoma kinase (<i>ALK</i> )-rearranged non-small cell lung cancer
Article Snippet: .. Cochrane Database of Systematic Reviews Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Quote: "Patients were randomly assigned in a 1:1 ratio, using a stratified permuted-block method" Allocation concealment (selection bias) Low risk Quote: "an interactive web response system (IxRS; EPS Corporation, Tokyo, Japan) using a randomisation code generated independently by the IxRS vendor." ..

Generated:

Article Title: Targeted therapy for advanced anaplastic lymphoma kinase (<i>ALK</i> )-rearranged non-small cell lung cancer
Article Snippet: .. Cochrane Database of Systematic Reviews Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Quote: "Patients were randomly assigned in a 1:1 ratio, using a stratified permuted-block method" Allocation concealment (selection bias) Low risk Quote: "an interactive web response system (IxRS; EPS Corporation, Tokyo, Japan) using a randomisation code generated independently by the IxRS vendor." ..



Similar Products

90
MedSciNet UK Ltd secure web-based randomisation program
Maternal demographic and pregnancy characteristics
Secure Web Based Randomisation Program, supplied by MedSciNet UK Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/secure+web-based+randomisation+program/secure+computerised+randomisation+system/pmc09545311-67-37-41
Average 90 stars, based on 1 article reviews
secure web-based randomisation program - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Maternal demographic and pregnancy characteristics

Journal: Bjog

Article Title: Two‐year follow‐up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre‐eclampsia ( PHOENIX ): A randomised controlled trial

doi: 10.1111/1471-0528.17167

Figure Lengend Snippet: Maternal demographic and pregnancy characteristics

Article Snippet: The only exclusion criterion to participation was the clinician’s decision to initiate delivery within the subsequent 48 h. After providing written informed consent, women were randomly assigned to planned delivery or expectant management via a secure web‐based randomisation program provided by MedSciNet.

Techniques: